Diphereline p.r. 11.25 mg powder for injection

Diphereline p.r. 11.25 mg powder for injection

Active ingredients: Triptorelin pamoate

Dosage Form: Powder for injection

Type of Dosage: Injectable

Mechanism of Action: Gonadotropin-releasing hormone (GnRH) agonist

Uses:

Prostate cancer: Diphereline p.r. 11.25 mg powder for injection is used to treat prostate cancer that has spread into surrounding tissue and/or to other parts of the body. It is not a cure for prostate cancer.

Central precocious puberty: Diphereline p.r. 11.25 mg powder for injection is used to treat central precocious puberty, which is a condition in which children reach sexual maturity too early.

Endometriosis: Diphereline p.r. 11.25 mg powder for injection is used to treat endometriosis, which is a condition in which the tissue that lines the uterus (endometrium) grows outside of the uterus.

How to use:

Diphereline p.r. 11.25 mg powder for injection is administered by deep intramuscular injection every 12 weeks. The injection should be given by a healthcare professional.

Diphereline p.r. 11.25 mg powder for injection is a long-acting GnRH agonist, which means that it is only administered once every 12 weeks. This makes it a convenient and effective treatment option for many patients.

Diphereline p.r. 11.25 mg powder for injection is also one of the few GnRH agonists that is FDA-approved for the treatment of central precocious puberty. This makes it a valuable treatment option for children with this condition.

Disclaimer: This information is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any medication.